Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Lublin

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1994
Characterization of DAF-2, a high molecular weight form of decay-accelerating factor (DAF; CD55), as a covalently cross-linked dimer of DAF-1M W Nickells, J I Alvarez, D M Lublin, et al.
The Journal of Experimental Medicine|May 1, 1985
Human genes for three complement components that regulate the activation of C3 are tightly linkedS Rodriguez de Cordoba, D M Lublin, P Rubinstein, et al.
The Journal of Experimental Medicine|December 1, 1993
Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interactionB Nowicki, A Hart, K E Coyne, et al.
The Journal of Biological Chemistry|June 2, 1995
Distinct tyrosine kinase activation and Triton X-100 insolubility upon Fc gamma RII or Fc gamma RIIIB ligation in human polymorphonuclear leukocytes. Implications for immune complex activation of the respiratory burstM J Zhou, D M Lublin, D C Link, et al.
Clinical and Experimental Immunology|June 1, 1987
The polymorphism of the C3b/C4b receptor in the normal population and in patients with systemic lupus erythematosusS Van Dyne, V M Holers, D M Lublin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1986
Biosynthesis and glycosylation of the human complement regulatory protein decay-accelerating factorD M Lublin, J Krsek-Staples, M K Pangburn, et al.
Arthritis and Rheumatism|February 24, 2001
Induction of endothelial cell decay-accelerating factor by vascular endothelial growth factor: a mechanism for cytoprotection against complement-mediated injury during inflammatory angiogenesisJ C Mason, E A Lidington, H Yarwood, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1995
Identification of complement regulatory domains in human factor HD L Gordon, R M Kaufman, T K Blackmore, et al.
FEBS Letters|June 17, 1996
Oligomerization of VIP21-caveolin in vitro is stabilized by long chain fatty acylation or cholesterolS Monier, D J Dietzen, W R Hastings, et al.
Immunology Today|October 8, 2014
Human C3b- and C4b-regulatory proteins: a new multi-gene familyV M Holers, J L Cole, D M Lublin, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1994
Characterization of DAF-2, a high molecular weight form of decay-accelerating factor (DAF; CD55), as a covalently cross-linked dimer of DAF-1M W Nickells, J I Alvarez, D M Lublin, et al.
The Journal of Experimental Medicine|May 1, 1985
Human genes for three complement components that regulate the activation of C3 are tightly linkedS Rodriguez de Cordoba, D M Lublin, P Rubinstein, et al.
The Journal of Experimental Medicine|December 1, 1993
Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interactionB Nowicki, A Hart, K E Coyne, et al.
The Journal of Biological Chemistry|June 2, 1995
Distinct tyrosine kinase activation and Triton X-100 insolubility upon Fc gamma RII or Fc gamma RIIIB ligation in human polymorphonuclear leukocytes. Implications for immune complex activation of the respiratory burstM J Zhou, D M Lublin, D C Link, et al.
Clinical and Experimental Immunology|June 1, 1987
The polymorphism of the C3b/C4b receptor in the normal population and in patients with systemic lupus erythematosusS Van Dyne, V M Holers, D M Lublin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1986
Biosynthesis and glycosylation of the human complement regulatory protein decay-accelerating factorD M Lublin, J Krsek-Staples, M K Pangburn, et al.
Arthritis and Rheumatism|February 24, 2001
Induction of endothelial cell decay-accelerating factor by vascular endothelial growth factor: a mechanism for cytoprotection against complement-mediated injury during inflammatory angiogenesisJ C Mason, E A Lidington, H Yarwood, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1995
Identification of complement regulatory domains in human factor HD L Gordon, R M Kaufman, T K Blackmore, et al.
FEBS Letters|June 17, 1996
Oligomerization of VIP21-caveolin in vitro is stabilized by long chain fatty acylation or cholesterolS Monier, D J Dietzen, W R Hastings, et al.
Immunology Today|October 8, 2014
Human C3b- and C4b-regulatory proteins: a new multi-gene familyV M Holers, J L Cole, D M Lublin, et al.
Pageof 7